medigraphic.com
ISSN 1560-4381 (Print)

2016, Number 4

<< Back Next >>

Correo Científico Médico 2016; 20 (4)

Conventional and sequential therapy in the treatment of Helicobacter pylori in patients of Carabobo state, Venezuela

Marval F, Brito A, Mora G, Piñeiro A, Bastidas J, Arteaga E, Bastidas PGA

Language: Spanish
References: 30
Page: 729-740
PDF size: 538.83 Kb.


ABSTRACT

Introduction: the worldwide trend, particularly in South American countries, is the increase in the casuistry of morbidity Helicobacter pylori that causes chronic gastritis so severe that fertile ground for the development of malignancies, this unfavorable situation for the population increase adds inconclusive reports on the effectiveness of conventional and sequential main therapy options for treating H. pylori.
Objective: to determine, in a first approach, from a sample of the Venezuelan population, the efficacy of sequential therapy and standard in the treatment of H. pylori in an attempt to provide information to help answer the question about which therapy is most effective.
Methods: a descriptive and retrospective study, based on a review of medical records was performed. The sample consisted of 84 individuals with a diagnosis of H. pylori infection in people gender, diagnosis of infection, diagnosis and therapy used post-treatment was determined.
Results: 67.9% were patients without post infection treatment, 50.9% of these subjects had received standard therapy and 49.1% sequential, without significant differences between the two.
Conclusions: in the studied sample and standard sequential therapy were equally effective in moderate proportion and in the treatment of H. pylori infection and also that this work is the first study in Venezuelan population.


REFERENCES

  1. Whalen M, Massidda O. Helicobacter pylori: enemy, commensal or, sometimes, friend? J Infect Dev Ctries. 2015[citado 13 dic 2015]; 9(6):674-678. Disponible en: http://www.jidc.org/index.php/journal/article/view/26142681

  2. Páez Valery M, Barón M, Solano L, Nadaff G, Boccio J, Barrado A. Helicobacter pylori infection (13C-UBT), and its relationship with nutritional and socioeconomic factors in low income school children from Valencia, Venezuela. Arch Latinoam Nutr. 2006[citado 12 nov 2015]; 56(4):342-349. Disponible en: http://www.scielo.org.ve/scielo.php?script=sci_abstract&pid=S0004-06222006000400005&lng=es&nrm=iso&tlng=en

  3. Contreras M, Fernández Delgado M, Reyes N, García Amado MA, Rojas H, Michelangeli F. Helicobacter pylori Infection in Rural and Urban Dyspeptic Patients from Venezuela. Am J Trop Med Hyg.2015[citado 7 dic 2015]; 93(4):730-732. Disponible en: http://www.ajtmh.org/content/93/4/730.abstract

  4. Ortiz D, Cavazza M, Rodríguez O, Hagel I, Correnti M, Convit J. Prevalence of Helicobacter pylori infection in Warao lineage communities of Delta Amacuro State. Venezuela. Mem Inst Oswaldo Cruz. 2003[citado 16 dic 2015]; 98 (6):7221-7225. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762003000600002&lng=en&nrm=iso&tlng=en

  5. Chose C, Pérez Pérez GI, van Doorn LJ, Domínguez Bello MG, Blaser MJ. High Frequency of Gastric colonization with multiple Helicobacter pylori Stains in Venezuela Subjects. J Clin Microbiol. 2005[citado 1 ene 2015]; 43(6):2635-2641. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=High+Frequency+of+Gastric+colonization

  6. Torre DC. Eficacia de la Terapia Secuencial en el tratamiento de Helicobacter pylori. Rev Gen. 2011[citado 24 mar 2015]; 65(2):85-91. Disponible en: http://www.scielo.org.ve/pdf/gen/v65n2/art04.pdf

  7. Masjedizadeh A, Zaeemzadeh N, Mard SA, Vanani GS. Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran. Prz Gastroenterol. 2015[citado 30 jul 2015]; 10(2):94-99. Disponible en: http://www.termedia.pl/Comparing-the-efficacy-of-four-different-protocols-for-eradicating-of-helicobacter-pylori-infection-in-Ahvaz-southwest-Iran,41,24567,0,0.html

  8. Malfertheiner P, Mégraud F, O'Morain C, Huging A, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002[citado 27 jul 2015]; 16(2):167-180. Disponible en: http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2036.2002.01169.x/full

  9. Haider RB, Brennan DE, Omorogbe J, Holleran G, Hall B, O'Morain C, et al. A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population. Eur J Gastroenterol Hepatol. 2015[citado 18 dic 2015]; 27(11):1265-1269. Disponible en: http://journals.lww.com/eurojgh/Abstract/2015/11000/A_randomized_controlled_study_to_compare_the.4.aspx

  10. Mehri N, Kambiz E, Ahmad K, Fatemeh F, Farzaneh M, Hossein FG, et al. The efficacy of a 1-week triple therapy for eradication of Helicobacter pylori infection in children. Arab J Gastroenterol. 2011[citado 1 ene 2015]; 12(1):37-39. Disponible en: http://www.sciencedirect.com/science/article/pii/S1687197911000141

  11. Gumurdulu Y, Serin E, Ozer B, Kayaselcuk F, Ozsahin K, Cosar A, et al. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J Gastroenterol. 2004[citado 30 nov 2015]; 10(5):668-671. Disponible en: http://www.wjgnet.com/1007-9327/full/v10/i5/668.htm

  12. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled‐data analysis. Gut. 2007[citado 23 abr 2015]; 56(10):1353-1357. Disponible en: http://gut.bmj.com/content/56/10/1353.abstract

  13. Sánchez Delgado J, Calvet X, Bujanda L, Gisbert JP, Titó L, Castro M. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol .2008 [citado 13 ene 2015]; 103(9): 2220-2223. Disponible en: http://www.nature.com/ajg/journal/v103/n9/full/ajg2008448a.html

  14. Greenberg E, Anderson G, Morgan D, Torres J, Chey W, Bravo L, et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011[citado 10 ago 2015]; 378(9790):507-514. Disponible en: http://www.sciencedirect.com/science/article/pii/S0140673611608258

  15. Zegarra Chang A, Bravo Paredes E, Prochazka Zárate R, Piscoya Rivera A, De Los Ríos Senmache R, Pinto Valdivia JL, et al. Estudio Piloto: terapia secuencial en la erradicación del Helicobacter Pylori en el Hospital Cayetano Heredia. Rev Gastroenterol Perú. 2011[citado 11 nov 2015]; 31(1):21-25. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1022-51292011000100005&script=sci_arttext

  16. Mattar R, Villares CA, Marostegam PF, Chaves CE, Pinto VB, Carrilho FJ. Low dose capsule based 13c-urea breath test compared with the conventional 13c-urea breath test and invasive tests. Arq Gastroenterol. 2014[citado 22 mar 2015]; 51(2):133-138. Disponible en: http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-28032014000200133&lng=en&nrm=iso&tlng=pt

  17. Chung JW, Ha M, Yun SCh, Ho Kim J, Jun Lee J, Kim Jae Y, et al. Meta-analysis: Sequential therapy is superior to conventional therapy for Helicobacter pylori Infection in Korea. Korean J Gastroenterol .2013 [citado 17 oct 2015]; 62(5):267-271. Disponible en: http://synapse.koreamed.org/DOIx.php?id=10.4166/kjg.2013.62.5.267&vmode=PUBREADER

  18. Gámez Escalona MM, Mulet Pérez A, Pozo Allen H, Verdecia Carralero AM. Histopatología de la mucosa bulbar en pacientes con úlcera duodenal y gastritis crónica antral por Helicobacter pylori. CCM. 2012 [citado 14 dic 2015]:16(4). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/491

  19. Mulet Pérez A, Gámez Escalona MM, Tamayo Ochoa M, Escobar Bernal A, Pozo Allen H, Verdecia Carralero AM. Gastritis crónica antral por Helicobacter pylori y enfermedad por reflujo gastroesofágico. CCM. 2012 [citado 14 dic 2015]:16(4). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/522

  20. Driggs Sánchez D, Cruz Aguilar T, Laurencio González I. Infección por Helicobacter pylori y cáncer gástrico. CCM. 2013 [citado 14 dic 2015]:17(2). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/1078/370

  21. Mulet Pérez A, Rodríguez Castro Y, Gámez Escalona MM, Rodríguez González L, Rodríguez Diéguez M, Matos Pérez MJ. Gastritis crónica antral por Helicobacter pylori en pacientes con y sin reflujo duodenogástrico. CCM. 2014 [citado 14 dic 2015]:18(1). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/1694

  22. García Niebla LM, Ricardo Zaldívar TD, Friman Suárez O. Virus, genes y cáncer. CCM. 2015 [citado 14 dic 2015]:19(2). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/2085/643

  23. Miranda Moles Z, Mulet Pérez AM, Gámez Escalona MM, Escobar Bernal A, Rodríguez Diéguez M, López Almaguer G. Gastritis crónica antral por Helicobacter pylori en pacientes con y sin consumo de antiinflamatorios no esteroideos. CCM. 2015 [citado 14 dic 2015]:19(1). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/1983/601

  24. Sierra M, Hastings E, Goodman K. What do we know about benefits of H. pylori treatment in childhood? Gut Microbes. 2013[citado 25 feb 2015]; 4(6):549-567. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928165/

  25. Sebastián de Marino Herrera H. Comparación de la triple terapia convencional con la terapia secuencial, en infecciones por Helicobacter pylori. Estudio realizado en un centro de gastroenterología privado en Guatemala. [Tesis]. Guatemala. Universidad Rafael Landívar. Facultad de Ciencias de la Salud; 2015 [citado 12 ene 2016]. Disponible en: http://recursosbiblio.url.edu.gt/tesiseortiz/2015/09/18/De-Mariano-Hugo.pdf

  26. Zhang M. High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment. World J Gastroenterol. 2015[citado 30 dic 2015]; 21(48):13432-13437. Disponible en: http://www.wjgnet.com/1007-9327/full/v21/i48/13432.htm

  27. Maçin S, Demir H, Özen H, Yüce A, Akyön Y. Determination of Helicobacter pylori antibiotic resistance patterns in pediatric gastroenterology patients: the Hacettepe experience. Turk J Pediatr. 2015[citado 4 ago 2015]; 57(3):254-257. Disponible en: http://www.turkishjournalpediatrics.org/abstract.php?lang=en&id=1471

  28. Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007[citado 6 jul 2015]; 56(6):772–781. Disponible en: http://gut.bmj.com/content/56/6/772.full

  29. Vallejos C, Garrido L, Cáceres D, Madrid AM, Defilippi C, Defilippi C, et al. Prevalencia de la resistencia a metrodinazol, claritromicina y tetraciclina en Helicobacter pylori aislado de pacientes de la Región Metropolitana. Rev Med Chile. 2007[citado 3 sep 2015]; 135(3):287–293. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000300002&lng=es&nrm=iso&tlng=es

  30. Trifan A, Girleanu I, Cojocariu C, Sfarti C, Singeap A, Dorobat C, et al. Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication. World J Gastroenterol.2013 [citado 22 sep 2015]; 19(42):7476-7479. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831232/




2020     |     www.medigraphic.com